TREM2 and Alzheimer disease: Here we describe the application of a multi-faceted, cross-sectional phenotyping approach developed by MODEL-AD that included biometrics, behavioral assays, transcriptomics, neuroimaging, and immunohistochemistry to assess AD-relevant phenotypes in mice expressing combinations of humanized APOEε4 and Trem2*R47H alleles.